Last reviewed · How we verify
NCT04211038
Assessment of Neural Inspiratory Time Through sEMG and EMGdi
NA trial testing inspiratory threshold load device in Copd in 30 participants. Status unknown.
30 December 2021
Quick facts
| Lead sponsor | Zhenfeng He |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 27 December 2019 |
| Primary completion | 30 December 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- inspiratory threshold load device
Conditions studied
- Copd — all drugs for Copd →
- Ventilation — all drugs for Ventilation →
- Rehabilitation — all drugs for Rehabilitation →
Sponsor
Zhenfeng He
Who can join
Adults 18 to 80, any sex, with Copd or Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The onset and offset of the neural inspiratory time are fundamentally important measurements in studies of patientventilator interaction, where the level of assistance delivered by the ventilator is controlled by the patient's demand. The onset of neural inspiratory time can be determined in esophageal pressure, transdiaphragmatic pressure, and EMG signals. The investigator compare the onset measured by EMG, esophageal and transdiaphragmatic pressure, and consider that the correlation between them is well in different conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04211038
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Copd
Currently open trials in the same condition.
- NCT06461403 — Inhaler Trainer Efficacy Study · NA · recruiting
- NCT07285642 — Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT07027852 — My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record · NA · recruiting
- NCT06286072 — The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD · NA · recruiting
- NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting
Other Zhenfeng He trials
Trials by the same sponsor.
- NCT04258982 — The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients With NIV Treatment · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04211038 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhenfeng He
- Last refreshed: 23 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04211038.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing